Abstract
An efficient synthesis of MLN4924, a small molecule inhibitor of NEDD8-activating enzyme (NAE) in clinical trial as an anticancer agent, has been accomplished via regioselective α-alkoxy removal by Al(Hg) and stereoselective reduction based on the conformational study as key steps. The present synthesis was achieved through a versatile cyclopentanone intermediate, which is expected to provide an easy access to structural analogues of MLN4924 for further exploration as a biologically privileged template.
Original language | English |
---|---|
Pages (from-to) | 2480-2487 |
Number of pages | 8 |
Journal | Organic Chemistry Frontiers |
Volume | 6 |
Issue number | 14 |
DOIs | |
State | Published - 2019 |
Bibliographical note
Funding Information:This work was supported by grants from Mid-career Research Program (2016R1A2B3010164) and the Ministry of Science, ICT & Future Planning (2017M3A9A8032086) of the National Research Foundation (NRF), Korea.
Publisher Copyright:
© the Partner Organisations 2019.